Stockton Hematology Oncology Medical Group, INC
Stockton Hematology Oncology Medical Group, INC was paid $8.18M by Medicaid between Jan 2018 and Dec 2024, across 33 billing codes. Its largest line is 78815, Positron emission tomography (PET) for limited area imaging — 33% of everything it billed.
33Billing provider infoSTOCKTON HEMATOLOGY ONCOLOGY MEDICAL GROUP, INC
STOCKTON, CA 95204
STOCKTON, CA 95204
33aNPI1922175074assigned 11/30/2006
33bProvider typeSpecialist
28Total paid$8.18M
24GClaims88,170
24DCodes billed33
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in California
Rank by total paid#22 of 1,230
Median peer was paid$51K
This provider vs. median159×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,960 | $1.38M | |
| 2019 | 9,793 | $1.05M | |
| 2020 | 12,588 | $804K | |
| 2021 | 9,720 | $980K | |
| 2022 | 10,250 | $820K | |
| 2023 | 16,365 | $1.73M | |
| 2024incomplete | 16,494 | $1.42M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 78815 | Positron emission tomography (PET) for limited area imaging | 33% | 2,344 | 1,461 | $2.73M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 14% | 13,546 | 7,172 | $1.11M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 23,147 | 21,339 | $1.04M |
| J0897 | Injection, denosumab, 1 mg | 6.5% | 221 | 204 | $532K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 5.7% | 1,451 | 1,427 | $467K |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 5.4% | 124 | 78 | $446K |
| 96367 | 4.6% | 8,309 | 4,557 | $379K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 4.5% | 2,300 | 1,220 | $370K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2.2% | 7,480 | 3,899 | $184K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.2% | 6,526 | 3,757 | $178K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.0% | 2,490 | 2,331 | $166K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.8% | 5,436 | 5,205 | $144K |
21 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,437 | $67K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 841 | $64K |
| 99205 | Prolong outpt/office vis | <1% | 596 | $60K |
| 96415 | <1% | 1,936 | $50K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 506 | $45K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 683 | $32K |
| 96523 | <1% | 973 | $22K | |
| 96417 | <1% | 656 | $19K | |
| 99245 | <1% | 136 | $19K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,857 | $13K |
| 99223 | Prolong inpt eval add15 m | <1% | 159 | $11K |
| 96368 | <1% | 535 | $9K | |
| J0640 | Injection, leucovorin calcium, per 50 mg | <1% | 84 | $7K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 149 | $6K |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 80 | $4K |
| 96401 | <1% | 15 | $3K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 12 | $1K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 42 | $738.18 |
| 96411 | <1% | 39 | $688.42 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 38 | $295.83 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 22 | $145.78 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMEHDI, AMINDER (PRESIDENT)